Home›Articles›Enavogliflozin against dapagliflozin in a 24-week trial added to metforminArticleEnavogliflozin against dapagliflozin in a 24-week trial added to metforminArticlesConnectionsSourcesComments (0)Reader Challenges (0)ConnectionsArticle OnEnavogliflozin, Drugs and Medicinal Substances Well-attested SourcesEfficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus (Diabetes & Metabolism Journal, 2023)Abstract, ConclusionQuote, Abstract, ConclusionEnavogliflozin added to metformin significantly improved glycemic control in patients with T2DM and was non-inferior to dapagliflozin 10 mgView the SourceMedicine Atlas Original Articlestier 1Comments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.